Breakthrough in Neuro-Therapeutics: Harnessing the Brain’s Glymphatic System to Deliver Precision Gene Therapy
For decades, the blood-brain barrier (BBB) has served as the ultimate fortress of the human body. Designed by evolution to...
therapeutics
Elixirgen Therapeutics: Pioneering Telomere Biology and Next-Generation mRNA Therapeutics
At the 2026 BIO International Convention in San Diego, the atmosphere was thick with discussions regarding the future of genetic...
The Twilight of a Pioneer: Sangamo Therapeutics Files for Chapter 11 Bankruptcy
In a somber turn of events for the biotechnology sector, Sangamo Therapeutics—a Bay Area-based company that effectively birthed the field...
AbbVie’s $10.9 Billion Acquisition of Apogee Therapeutics: A Strategic Pivot in the Immunology Arms Race
SAN DIEGO — In a move that signals a significant intensification of the global battle for dominance in the immunology...
Intellia Therapeutics: A New Paradigm for Hereditary Angioedema as Gene Editing Nears Commercial Reality
In the rapidly evolving landscape of genetic medicine, few companies have captured the attention of Wall Street and the clinical...
